US approval for Israeli ECG system

The US FDA has approved the innovative ECG system HyperQ Analyzer Rest developed by Israeli biotech BSP.  HyperQ can test patients at rest, diagnosing early-stage heart disease without putting the patient under stress. It is less risky than alternative invasive and radioactivity tests.

http://news.nocamels.com/2014/10/29/bsp-receives-fda-approval-for-hyperq-rest-system/

https://www.youtube.com/watch?v=W2xANqegvOg

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *